Physician profile
Leann Maxwell
NPI 1598184574
$1,721.68
in general payments reported to CMS, 2019-2025
11 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $338 · 2023: $197 · 2024: $487 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $544.46 | 2021-2025 | Austedo Xr, Austedo, Uzedy |
| Novo Nordisk INC | $204.52 | 2023-2025 | Wegovy |
| Myriad Genetic Laboratories, INC. | $181.22 | 2024-2025 | Myrisk |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.45 | 2021-2022 | |
| Scynexis, INC. | $130.48 | 2022 | |
| Viiv Healthcare Company | $124.73 | 2024 | |
| Xeris Pharmaceuticals, INC. | $112.67 | 2022 | |
| Aimmune Therapeutics, INC. | $90.91 | 2024 | |
| Abbott Laboratories | $81.15 | 2025 | Alinity |
| Medtronic, INC. | $55.60 | 2025 | Symplicity G3 |
| Janssen Pharmaceuticals, INC | $25.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leann Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.